Fluidra/€FDR

1D1W1MYTD1Y5YMAX

About Fluidra

Fluidra SA, traded under ticker FDR, is a Spanish multinational company focused on developing and providing products, systems, and services for the residential and commercial pool and wellness markets. Founded in 1969, Fluidra operates globally, with its product portfolio encompassing pool equipment, water treatment products, and connectivity solutions. The company is known for its commitment to innovation and sustainability within the pool and wellness sectors.
Ticker
€FDR
Primary listing
BME
Employees
7,336

Fluidra Metrics

BasicAdvanced
€3.4B
20.28
€0.88
0.82
€0.50
2.83%

What the Analysts think about Fluidra

Analyst ratings (Buy, Hold, Sell) for Fluidra stock.
Analyst projections of the future price of Fluidra stock.

Bulls say / Bears say

In Q2 2026, Fluidra reported revenues of €694 million (up 5 % year-over-year and 4 % organic) and adjusted EBITDA of €197 million, yielding a 28.4 % margin that beat consensus by roughly 60 basis points, underscoring strong operational execution (Investing.com)
The company confirmed its full-year 2026 guidance—targeting 3-7 % organic growth and 23.3-24.3 % EBITDA margins—and launched a €40 million share buyback program, reflecting management’s confidence in cash flow generation and strategic outlook (Investing.com)
Geographic diversification drove resilience, with Southern Europe posting 9 % organic growth and the U.S. growing 3 % in Q2 2026, demonstrating strength across key markets (Investing.com)
In Q1 2026, Fluidra’s adjusted EBITDA of €124 million fell short of the €132 million consensus and its cash earnings per share of €0.32 missed the €0.34 forecast, highlighting challenges in meeting analyst expectations (Investing.com)
Reported net profit declined 4.6 % year-on-year to €46 million in Q1 2026, driven by adverse foreign exchange impacts that underscore the company’s significant currency exposure risk (Yahoo Finance)
Fluidra’s 2026 Annual Non-Financial Information Statement warns that its pool chemicals segment faces stringent EU REACH and Biocidal Products Regulation compliance, which could raise operating costs and add regulatory complexity (FinancialReports.eu)
Data summarised monthly by Lightyear AI. Last updated on 21 Aug 2026.

Fluidra Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Fluidra Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Fluidra

AllEURGBPUSD
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.